HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José Manuel Martín-Villa Selected Research

Therapeutics

1/2013Two functional variants of IRF5 influence the development of macular edema in patients with non-anterior uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José Manuel Martín-Villa Research Topics

Disease

2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2013
2Uveitis
04/2015 - 05/2013
2Anterior Uveitis
05/2013 - 01/2013
1Neoplasms (Cancer)
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Hepatomegaly
06/2021
1Fatty Liver
06/2021
1Disease Susceptibility (Diathesis)
01/2021
1Adenocarcinoma
01/2021
1Birdshot Chorioretinopathy
01/2017
1Posterior Uveitis
01/2017
1Infections
03/2014
1Wiskott-Aldrich Syndrome
03/2014
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2013
1Macular Edema
01/2013
1Acquired Immunodeficiency Syndrome (AIDS)
05/2009

Drug/Important Bio-Agent (IBA)

2HLA-G Antigens (HLA G)IBA
01/2022 - 01/2021
23' Untranslated Regions (3' UTR)IBA
01/2022 - 01/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2021
1Alanine Transaminase (SGPT)IBA
06/2021
1RNA (Ribonucleic Acid)IBA
06/2021
1P-2 (P 2)IBA
01/2017
1HLA-DR15 antigenIBA
01/2017
1HLA-A Antigens (HLA-A)IBA
01/2017
1HLA-DR alpha-ChainsIBA
01/2017
1CytokinesIBA
04/2015
1Tyrosine (L-Tyrosine)FDA Link
03/2014
1Proteins (Proteins, Gene)FDA Link
03/2014
1Interleukin-2 (IL2)IBA
05/2013
1interleukin-21 (interleukin 21)IBA
05/2013
1Genetic Markers (Genetic Marker)IBA
01/2013
1Non-Receptor Type 22 Protein Tyrosine PhosphataseIBA
01/2013
1Interferon Regulatory FactorsIBA
01/2013
1Interferon Type IIBA
01/2013
1HLA-B35 Antigen (HLA B35 Antigen)IBA
05/2009

Therapy/Procedure

1Organ Transplantation
01/2022
1Therapeutics
01/2013